Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

01-10-2018

https://doi.org/10.4081/dr.2018.7859

1932

PDF: 1040

HTML: 62
Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek

11-04-2025

https://doi.org/10.4081/dr.2025.10124

495

PDF: 331

HTML: 1
Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

29-07-2021

https://doi.org/10.4081/dr.2021.8797

3043

PDF: 634

HTML: 8
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1922

PDF: 710

HTML: 27
Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

13-03-2025

https://doi.org/10.4081/dr.2025.10021

425

PDF: 285

HTML: 2
Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

21-02-2025

https://doi.org/10.4081/dr.2025.10278

440

PDF: 281

HTML: 8
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

01-07-2025

https://doi.org/10.4081/dr.2025.10315

482

PDF: 228

HTML: 6
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

554

PDF: 335

HTML: 7
A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

Shinpei Miura, Kanako Tsunoda, Hiroo Amano

05-06-2023

https://doi.org/10.4081/dr.2023.9699

721

PDF: 431

HTML: 14
Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami

06-12-2024

https://doi.org/10.4081/dr.2024.10171

1468

PDF: 415

HTML: 28
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1036

PDF: 548

HTML: 69
Isotretinoin musculoskeletal side effects: a systematic review

Rahaf R. Almutairi, Atheer G. Almutairi, Afnan F. Alhallafi, Norah A. Almudawi, Mohammed Abdulaziz AlSulaiman, Asem M. Shadid, Ruaa Alharithy

12-04-2024

https://doi.org/10.4081/dr.2024.9845

4405

PDF: 1084

SUPPLEMENTARY: 204

HTML: 435
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1151

PDF: 806

HTML: 40
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1711

PDF: 647

HTML: 93
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1764

PDF: 504

HTML: 75
Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

Mitchell Hanson, McKenzie E. Maloney, Louis Kuchnir

08-02-2024

https://doi.org/10.4081/dr.2024.9866

1180

PDF: 729

HTML: 10
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1009

PDF: 529

HTML: 25
Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

04-02-2025

https://doi.org/10.4081/dr.2025.10232

491

PDF: 288

HTML: 6
A microRNA focus on acne

Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

02-02-2024

https://doi.org/10.4081/dr.2024.9902

1052

PDF: 704

HTML: 54
Hidradenitis suppurativa: state-of-the-art review and update

Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola

27-08-2025

https://doi.org/10.4081/dr.2025.10328

518

PDF: 496
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

25-06-2020

https://doi.org/10.4081/dr.2020.8642

1335

PDF: 738

HTML: 3
Secondary prevention of hidradenitis suppurativa

Hjalmar Kurzen, Marina Kurzen

25-10-2019

https://doi.org/10.4081/dr.2019.8243

2783

PDF: 1185

HTML: 23
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2611

PDF: 620

HTML: 6
Treatment modalities of necrobiosis lipoidica: a concise systematic review

Amir Feily, Shadi Mehraban

08-06-2015

https://doi.org/10.4081/dr.2015.5749

2860

PDF: 1877

Suppl. Table: 430

HTML: 491
Papillon-Lefèvre syndrome with excellent response to risankizumab

Latifah Alibrahim, Sarah Alrashid, Majed Aleissa

25-02-2026

https://doi.org/10.4081/dr.2026.10309

141

PDF: 138

1 - 25 of 32 items 1 2 > >>

Search

Search Results

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Certolizumab to treat hidradenitis suppurativa

Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Isotretinoin musculoskeletal side effects: a systematic review

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

A microRNA focus on acne

Hidradenitis suppurativa: state-of-the-art review and update

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Secondary prevention of hidradenitis suppurativa

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Treatment modalities of necrobiosis lipoidica: a concise systematic review

Papillon-Lefèvre syndrome with excellent response to risankizumab

authors

reviewers

Categories

indexing

dermatopathology